Annual Revenue
$674.98 M
+$8.15 M+1.22%
December 31, 2023
Summary
- As of February 21, 2025, PCRX annual revenue is $674.98 million, with the most recent change of +$8.15 million (+1.22%) on December 31, 2023.
- During the last 3 years, PCRX annual revenue has risen by +$245.33 million (+57.10%).
- PCRX annual revenue is now at all-time high.
Performance
PCRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$168.57 M
-$9.45 M-5.31%
September 30, 2024
Summary
- As of February 21, 2025, PCRX quarterly revenue is $168.57 million, with the most recent change of -$9.45 million (-5.31%) on September 30, 2024.
- Over the past year, PCRX quarterly revenue has increased by +$4.65 million (+2.83%).
- PCRX quarterly revenue is now -6.99% below its all-time high of $181.24 million, reached on December 31, 2023.
Performance
PCRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$694.96 M
+$4.65 M+0.67%
September 30, 2024
Summary
- As of February 21, 2025, PCRX TTM revenue is $694.96 million, with the most recent change of +$4.65 million (+0.67%) on September 30, 2024.
- Over the past year, PCRX TTM revenue has increased by +$29.27 million (+4.40%).
- PCRX TTM revenue is now at all-time high.
Performance
PCRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
PCRX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.2% | +2.8% | +4.4% |
| 3 y3 years | +57.1% | +6.7% | +19.7% |
| 5 y5 years | +100.1% | +6.7% | +19.7% |
PCRX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.6% | -7.0% | +6.7% | at high | +28.3% |
| 5 y | 5-year | at high | +60.3% | -7.0% | +123.3% | at high | +70.2% |
| alltime | all time | at high | +4747.2% | -7.0% | +7593.9% | at high | >+9999.0% |
Pacira BioSciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $168.57 M(-5.3%) | $694.96 M(+0.7%) |
| Jun 2024 | - | $178.02 M(+6.5%) | $690.31 M(+1.3%) |
| Mar 2024 | - | $167.12 M(-7.8%) | $681.75 M(+1.0%) |
| Dec 2023 | $674.98 M(+1.2%) | $181.24 M(+10.6%) | $674.98 M(+1.4%) |
| Sep 2023 | - | $163.93 M(-3.3%) | $665.69 M(-0.5%) |
| Jun 2023 | - | $169.47 M(+5.7%) | $669.23 M(+0.0%) |
| Mar 2023 | - | $160.34 M(-6.8%) | $669.17 M(+0.4%) |
| Dec 2022 | $666.82 M(+23.1%) | $171.96 M(+2.7%) | $666.82 M(+2.0%) |
| Sep 2022 | - | $167.47 M(-1.1%) | $654.06 M(+6.5%) |
| Jun 2022 | - | $169.41 M(+7.2%) | $614.32 M(+5.8%) |
| Mar 2022 | - | $157.99 M(-0.8%) | $580.50 M(+7.2%) |
| Dec 2021 | $541.53 M(+26.0%) | $159.19 M(+24.6%) | $541.53 M(+5.5%) |
| Sep 2021 | - | $127.72 M(-5.8%) | $513.31 M(+2.0%) |
| Jun 2021 | - | $135.59 M(+13.9%) | $503.07 M(+13.6%) |
| Mar 2021 | - | $119.03 M(-9.1%) | $442.99 M(+3.1%) |
| Dec 2020 | $429.65 M(+2.0%) | $130.97 M(+11.5%) | $429.65 M(+2.0%) |
| Sep 2020 | - | $117.48 M(+55.6%) | $421.10 M(+3.1%) |
| Jun 2020 | - | $75.50 M(-28.6%) | $408.30 M(-6.2%) |
| Mar 2020 | - | $105.68 M(-13.7%) | $435.40 M(+3.4%) |
| Dec 2019 | $421.03 M(+24.8%) | $122.42 M(+16.9%) | $421.03 M(+6.9%) |
| Sep 2019 | - | $104.69 M(+2.0%) | $393.72 M(+5.7%) |
| Jun 2019 | - | $102.60 M(+12.4%) | $372.48 M(+5.2%) |
| Mar 2019 | - | $91.31 M(-4.0%) | $353.98 M(+5.0%) |
| Dec 2018 | $337.28 M(+17.7%) | $95.11 M(+14.0%) | $337.28 M(+5.0%) |
| Sep 2018 | - | $83.45 M(-0.8%) | $321.24 M(+5.3%) |
| Jun 2018 | - | $84.11 M(+12.7%) | $305.13 M(+4.5%) |
| Mar 2018 | - | $74.61 M(-5.7%) | $291.95 M(+1.9%) |
| Dec 2017 | $286.63 M(+3.7%) | $79.08 M(+17.4%) | $286.63 M(+2.2%) |
| Sep 2017 | - | $67.33 M(-5.1%) | $280.45 M(-0.4%) |
| Jun 2017 | - | $70.93 M(+2.4%) | $281.47 M(+0.5%) |
| Mar 2017 | - | $69.28 M(-5.0%) | $280.18 M(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $276.37 M(+11.0%) | $72.90 M(+6.7%) | $276.37 M(+1.3%) |
| Sep 2016 | - | $68.36 M(-1.8%) | $272.79 M(+2.3%) |
| Jun 2016 | - | $69.64 M(+6.4%) | $266.65 M(+4.1%) |
| Mar 2016 | - | $65.47 M(-5.5%) | $256.16 M(+2.9%) |
| Dec 2015 | $249.00 M(+26.0%) | $69.32 M(+11.4%) | $249.00 M(+3.1%) |
| Sep 2015 | - | $62.21 M(+5.2%) | $241.47 M(+4.4%) |
| Jun 2015 | - | $59.15 M(+1.4%) | $231.30 M(+5.5%) |
| Mar 2015 | - | $58.32 M(-5.6%) | $219.32 M(+11.0%) |
| Dec 2014 | $197.67 M(+131.1%) | $61.79 M(+18.7%) | $197.67 M(+16.7%) |
| Sep 2014 | - | $52.05 M(+10.4%) | $169.44 M(+20.5%) |
| Jun 2014 | - | $47.16 M(+28.6%) | $140.65 M(+27.1%) |
| Mar 2014 | - | $36.66 M(+9.2%) | $110.63 M(+29.3%) |
| Dec 2013 | $85.55 M(+118.9%) | $33.56 M(+44.3%) | $85.55 M(+37.0%) |
| Sep 2013 | - | $23.26 M(+35.7%) | $62.44 M(+31.0%) |
| Jun 2013 | - | $17.14 M(+47.9%) | $47.66 M(+11.2%) |
| Mar 2013 | - | $11.59 M(+10.9%) | $42.87 M(+9.7%) |
| Dec 2012 | $39.08 M(+149.1%) | $10.45 M(+23.1%) | $39.08 M(+18.9%) |
| Sep 2012 | - | $8.49 M(-31.3%) | $32.87 M(+16.0%) |
| Jun 2012 | - | $12.34 M(+58.2%) | $28.34 M(+44.4%) |
| Mar 2012 | - | $7.80 M(+84.4%) | $19.63 M(+25.1%) |
| Dec 2011 | $15.69 M(+7.7%) | $4.23 M(+7.0%) | $15.69 M(+15.0%) |
| Sep 2011 | - | $3.96 M(+8.8%) | $13.65 M(-4.1%) |
| Jun 2011 | - | $3.64 M(-5.9%) | $14.22 M(+4.3%) |
| Mar 2011 | - | $3.86 M(+76.3%) | $13.64 M(-6.3%) |
| Dec 2010 | $14.56 M(-3.0%) | $2.19 M(-51.7%) | $14.56 M(-12.6%) |
| Sep 2010 | - | $4.53 M(+48.3%) | $16.66 M(+4.9%) |
| Jun 2010 | - | $3.06 M(-36.1%) | $15.88 M(+23.8%) |
| Mar 2010 | - | $4.78 M(+11.7%) | $12.83 M(+59.5%) |
| Dec 2009 | $15.01 M(+7.8%) | $4.28 M(+13.9%) | $8.04 M(+113.9%) |
| Sep 2009 | - | $3.76 M | $3.76 M |
| Dec 2008 | $13.93 M | - | - |
FAQ
- What is Pacira BioSciences annual revenue?
- What is the all time high annual revenue for Pacira BioSciences?
- What is Pacira BioSciences annual revenue year-on-year change?
- What is Pacira BioSciences quarterly revenue?
- What is the all time high quarterly revenue for Pacira BioSciences?
- What is Pacira BioSciences quarterly revenue year-on-year change?
- What is Pacira BioSciences TTM revenue?
- What is the all time high TTM revenue for Pacira BioSciences?
- What is Pacira BioSciences TTM revenue year-on-year change?
What is Pacira BioSciences annual revenue?
The current annual revenue of PCRX is $674.98 M
What is the all time high annual revenue for Pacira BioSciences?
Pacira BioSciences all-time high annual revenue is $674.98 M
What is Pacira BioSciences annual revenue year-on-year change?
Over the past year, PCRX annual revenue has changed by +$8.15 M (+1.22%)
What is Pacira BioSciences quarterly revenue?
The current quarterly revenue of PCRX is $168.57 M
What is the all time high quarterly revenue for Pacira BioSciences?
Pacira BioSciences all-time high quarterly revenue is $181.24 M
What is Pacira BioSciences quarterly revenue year-on-year change?
Over the past year, PCRX quarterly revenue has changed by +$4.65 M (+2.83%)
What is Pacira BioSciences TTM revenue?
The current TTM revenue of PCRX is $694.96 M
What is the all time high TTM revenue for Pacira BioSciences?
Pacira BioSciences all-time high TTM revenue is $694.96 M
What is Pacira BioSciences TTM revenue year-on-year change?
Over the past year, PCRX TTM revenue has changed by +$29.27 M (+4.40%)